Nasonex Delivery Failures Are Among Observations In Schering FDA-483s

One theme of FDA's recent inspections of Schering-Plough's Manati, Puerto Rico manufacturing facility is the reliability of the nasal spray delivery system for Nasonex (mometasone).

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet